Painkillers sales will rise through 2035, driven by opioids at 41.6% share of the drug class segment in 2025. OTC products hold 57.2% share of the product segment in 2025. The market is expected to reach USD 75.3 billion in 2025 and USD 108.3 billion by 2035 across healthcare settings.